Hospital Rio Carrion

Recent papers from Hospital Rio Carrion

1. Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survivalBritish Journal of Haematology · 2026
2. B32-13 Clinical and Biological Remission in Severe Asthma Treated With Tezepelumab: Evidence From a Multicentre Real-World Cohort in SpainAmerican Journal of Respiratory and Critical Care Medicine · 2026
3. Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real‐world analysis from the PETHEMA registryCancer · 2026
4. Baseline Composite Score for 12-Month Clinical Remission in Biologic-Treated Severe Asthma: Development of the Base4ScoreBiomedicines · 2026
5. Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature reviewRMD Open · 2026
6. Pneumocystis jirovecii pneumonia in patients with and without HIV infection: A multicentre comparative studyInternational Journal of Infectious Diseases · 2026
7. Multidomain clinical and biological remission with tezepelumab in severe asthma: a 12-month multicentre real-world studyRespiratory Research · 2026
8. P0647Rapid enhancement of Quality of Life after ustekinumab initiation in patients with Ulcerative Colitis: Results from a prospective study using the SIBDQ-9Journal of Crohn s and Colitis · 2026
9. Consensus document on the diagnosis and treatment of acute kidney injuryNefrología (English Edition) · 2026
10. Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in SpainBlood · 2025
11. Assessment of the risk of osteoporotic bone fracture in postmenopausal women using machine learning methodsScientific Reports · 2025
12. Effectiveness of Gilteritinib Beyond Second‐Line Therapy in Relapsed/Refractory FLT3 ‐Mutated Acute Myeloid Leukemia: A Real‐World Multicenter Study of 171 PatientsAmerican Journal of Hematology · 2025
13. Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell TransplantationClinical Lymphoma Myeloma & Leukemia · 2025
14. Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosisNeurología (English Edition) · 2025
15. Immunologic biomarkers of noninfectious complications and overall survival in common variable immunodeficiencyJournal of Allergy and Clinical Immunology · 2025
16. Does Combining a Mobile Dose Calculation App with a Continuous Insulin Infusion System Improve Glycemic Control and Quality of Life Compared with a Hybrid System in Patients with Type 1 Diabetes? A Descriptive Open-Label Sequential Study.2025
17. Infectious complications in acquired haemophilia A: Insights from the Spanish Registry (AHASR)Haematologica · 2025
18. Real-world data on avelumab in first-line maintenance therapy for advanced or metastatic urothelial carcinoma: the SOGUG-AVELUMAB RWD studyClinical & Translational Oncology · 2025
19. Improving prediction of fragility fractures in postmenopausal women using random forestComputers in Biology and Medicine · 2025
20. Silent protocol modifications in multiple sclerosis clinical trials: a registry-based cross-sectional studyTherapeutic Advances in Neurological Disorders · 2025